Quantbot Technologies’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $910K | Buy |
+1,460
| New | +$994K | 0.04% | 682 |
|
|
2025
Q4 | – | Sell |
-405
| Closed | -$228K | – | 2090 |
|
|
2025
Q3 | $228K | Sell |
405
-902
| -69% | -$510K | 0.01% | 1256 |
|
|
2025
Q2 | $686K | Sell |
1,307
-457
| -26% | -$255K | 0.02% | 909 |
|
|
2025
Q1 | $1.12M | Buy |
1,764
+1,236
| +234% | +$850K | 0.04% | 638 |
|
|
2024
Q4 | $376K | Buy |
528
+384
| +267% | +$322K | 0.01% | 902 |
|
|
2024
Q3 | $151K | Buy |
+144
| New | +$160K | 0.01% | 1078 |
|
|
2024
Q2 | – | Sell |
-114
| Closed | -$110K | – | 1833 |
|
|
2024
Q1 | $110K | Sell |
114
-663
| -85% | -$630K | 0.01% | 1149 |
|
|
2023
Q4 | $682K | Buy |
777
+668
| +613% | +$550K | 0.04% | 618 |
|
|
2023
Q3 | $89.7K | Buy |
+109
| New | +$85.7K | 0.01% | 1121 |
|
|
2023
Q2 | – | Sell |
-589
| Closed | -$484K | – | 1894 |
|
|
2023
Q1 | $484K | Buy |
+589
| New | +$444K | 0.03% | 619 |
|
|
2022
Q4 | – | Sell |
-139
| Closed | -$95K | – | 2038 |
|
|
2022
Q3 | $95K | Buy |
+139
| New | +$87.5K | 0.01% | 1102 |
|
|
2022
Q1 | – | Sell |
-546
| Closed | -$344K | – | 1984 |
|
|
2021
Q4 | $344K | Sell |
546
-3,330
| -86% | -$2.05M | 0.03% | 613 |
|
|
2021
Q3 | $2.35M | Sell |
3,876
-13,903
| -78% | -$8.63M | 0.17% | 162 |
|
|
2021
Q2 | $9.93M | Buy |
17,779
+16,957
| +2,063% | +$8.59M | 0.78% | 8 |
|
|
2021
Q1 | $388K | Sell |
822
-3,727
| -82% | -$1.81M | 0.04% | 556 |
|
|
2020
Q4 | $2.2M | Sell |
4,549
-10
| -0.2% | -$5.4K | 0.23% | 131 |
|
|
2020
Q3 | $2.55M | Buy |
+4,559
| New | +$2.76M | 0.29% | 101 |
|
|
2019
Q3 | – | Sell |
-8,978
| Closed | -$2.81M | – | 1518 |
|
|
2019
Q2 | $2.81M | Buy |
8,978
+4,878
| +119% | +$1.62M | 0.28% | 101 |
|
|
2019
Q1 | $1.68M | Sell |
4,100
-5,691
| -58% | -$2.34M | 0.16% | 173 |
|
|
2018
Q4 | $3.66M | Buy |
9,791
+8,730
| +823% | +$3.2M | 0.36% | 72 |
|
|
2018
Q3 | $428K | Buy |
+1,061
| New | +$404K | 0.03% | 579 |
|
|
2018
Q1 | – | Sell |
-3,778
| Closed | -$1.42M | – | 1476 |
|
|
2017
Q4 | $1.42M | Buy |
+3,778
| New | +$1.53M | 0.13% | 232 |
|
|
2017
Q3 | – | Sell |
-962
| Closed | -$472K | – | 1391 |
|
|
2017
Q2 | $472K | Buy |
962
+690
| +254% | +$302K | 0.04% | 450 |
|
|
2017
Q1 | $105K | Sell |
272
-425
| -61% | -$158K | 0.01% | 784 |
|
|
2016
Q4 | $255K | Buy |
+697
| New | +$265K | 0.03% | 497 |
|
|
2016
Q3 | – | Sell |
-29
| Closed | -$10K | – | 1281 |
|
|
2016
Q2 | $10K | Sell |
29
-2,880
| -99% | -$1.11M | ﹤0.01% | 969 |
|
|
2016
Q1 | $1.05M | Buy |
2,909
+813
| +39% | +$335K | 0.17% | 173 |
|
|
2015
Q4 | $1.14M | Sell |
2,096
-8,294
| -80% | -$4.49M | 0.2% | 136 |
|
|
2015
Q3 | $4.83M | Buy |
10,390
+9,152
| +739% | +$4.91M | 0.84% | 12 |
|
|
2015
Q2 | $631K | Buy |
+1,238
| New | +$604K | 0.11% | 185 |
|
|
2014
Q3 | – | Sell |
-1,855
| Closed | -$523K | – | 1350 |
|
|
2014
Q2 | $523K | Buy |
+1,855
| New | +$550K | 0.08% | 345 |
|
Other funds holding REGN
Quantbot Technologies's REGN Position: Q2 2026 in Review
Quantbot Technologies opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 1,460 shares worth $910K. The stake represents 0.04% of the portfolio and ranks #682 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in REGN as recently as Q3 2025.
Quantbot Technologies first reported a position in REGN in Q2 2014 and has held it in 31 quarters since. The position peaked at $9.93M in Q2 2021. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Quantbot Technologies held 1,460 shares of Regeneron Pharmaceuticals worth $910K as of Q2 2026.
- Regeneron Pharmaceuticals was a new Quantbot Technologies position in Q2 2026.
- Regeneron Pharmaceuticals made up 0.04% of Quantbot Technologies's portfolio in Q2 2026, its #682 holding.
- Quantbot Technologies first reported a position in Regeneron Pharmaceuticals in Q2 2014 and has held it in 31 quarters since.
- Quantbot Technologies's Regeneron Pharmaceuticals position peaked at $9.93M in Q2 2021.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.